My ePortfolio Register   

New editorial exploring how personalised medicine can be used to shape healthcare policy

We have just published an editorial by Denis Horgan of the European Alliance for Personalised Medicine (EAPM), which  discusses the barriers involved in getting novel drugs and treatments swiftly to where they are really needed. 

Factors such as slow bench-to-bedside rates are negatively affecting cancer patients across the EU. Horgan describes how personalised medicine can improve the situation, holding huge potential for improving the health of many patients and ensuring better outcomes for health systems’ efficiency and transparency.

Read the full editorial here.

Watch this video for more on health economics.

 

Related news

none present



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence